Pro-Cure Therapeutics
York
About Pro-Cure Therapeutics
Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $2.2M
- Last round: Series Unknown (Apr 2010)
- Website: pro-cure.uk.com
- Phone: 44 1904 435 125
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/pro-cure-therapeutics-2637562 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.